Company: BIAF
Filing Date: 2025-08-13
Form Type: 8-K
Source: 0001641172-25-023488
Chunk: 0

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-08-13
Form: 8-K
Item: Item 3.01
Chunk 0
---
Item
3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

As
previously reported in a Current Report on Form 8-K filed by bioAffinity Technologies, Inc. (the “ Company”), on February
7, 2025, the Company received written notice from the Listing Qualifications Department (the “ Staff”)
of The Nasdaq Stock Market LLC (“ Nasdaq”) notifying the Company that for the preceding 30 consecutive business days (December
23, 2024 through February 6, 2025), the Company’s common stock did not maintain a minimum closing bid price of $1.00 (“ Minimum
Bid Price Requirement”) per share as required by Nasdaq Listing Rule 5550(a)(2). Therefore, in accordance with Nasdaq Listing Rule
5810(c)(3)(A), the Company was provided 180 calendar days, or util August 6, 2025, to regain compliance with the rule.

As
previously reported in a Current Report on Form 8-K filed by the Company, on May 27, 2025 the Company received
written notice from the Staff stating that the Company was not in compliance with Nasdaq Listing Rule 5550(b)(1) (the “ Continued
Listing Equity Requirement”) because the stockholders’ equity of the Company of $1,439,404 as of March 31, 2025, as reported
in the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 15, 2025, was below the minimum requirement of $2,500,000.
Pursuant to Nasdaq’s Listing Rules, the Company had 45 calendar days to submit a plan (a “ Compliance Plan”) to regain
compliance with the Continued Listing Equity Requirement. On July 14, 2025, the Company submitted its plan to regain compliance with
the Continued Listing Equity Requirement.

On
August 7, 2025, the Company received written notice from the Listing Qualifications Staff of Nasdaq that the Company has not regained
compliance with the Minimum Bid Price Requirement by August 6, 2025 and is not eligible for a second 180 day compliance period as the
Company does not comply with the minimum stockholders’ equity requirement for initial listing on the Nasdaq Capital Market. As
a result, unless the Company requests an appeal to a hearings panel (the “ Panel”) by August 14, 202